Biorem Inc Stock Fundamentals

BRM Stock  CAD 2.08  0.07  3.48%   
BioRem Inc fundamentals help investors to digest information that contributes to BioRem's financial success or failures. It also enables traders to predict the movement of BioRem Stock. The fundamental analysis module provides a way to measure BioRem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioRem stock.
At this time, BioRem's Operating Income is fairly stable compared to the past year. EBIT is likely to climb to about 3.2 M in 2024, whereas Total Revenue is likely to drop slightly above 18.5 M in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

BioRem Inc Company Operating Margin Analysis

BioRem's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current BioRem Operating Margin

    
  0.25 %  
Most of BioRem's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioRem Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

BioRem Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for BioRem is extremely important. It helps to project a fair market value of BioRem Stock properly, considering its historical fundamentals such as Operating Margin. Since BioRem's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BioRem's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BioRem's interrelated accounts and indicators.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

BioRem Pretax Profit Margin

Pretax Profit Margin

0.12

At this time, BioRem's Pretax Profit Margin is fairly stable compared to the past year.
Based on the recorded statements, BioRem Inc has an Operating Margin of 0.2481%. This is 95.4% lower than that of the Machinery sector and 101.21% lower than that of the Industrials industry. The operating margin for all Canada stocks is 104.5% lower than that of the firm.

BioRem Inc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BioRem's current stock value. Our valuation model uses many indicators to compare BioRem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioRem competition to find correlations between indicators driving BioRem's intrinsic value. More Info.
BioRem Inc is rated third in return on equity category among related companies. It is rated third in return on asset category among related companies reporting about  0.22  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for BioRem Inc is roughly  4.50 . At this time, BioRem's Return On Equity is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value BioRem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioRem's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioRem's earnings, one of the primary drivers of an investment's value.

BioRem Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioRem's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioRem could also be used in its relative valuation, which is a method of valuing BioRem by comparing valuation metrics of similar companies.
BioRem is currently under evaluation in operating margin category among related companies.

BioRem Current Valuation Drivers

We derive many important indicators used in calculating different scores of BioRem from analyzing BioRem's financial statements. These drivers represent accounts that assess BioRem's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BioRem's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap15.5M20.9M32.3M13.6M12.3M9.6M
Enterprise Value9.1M12.8M33.5M14.6M13.1M9.0M

BioRem Fundamentals

About BioRem Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BioRem Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioRem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioRem Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue4.3 M4.5 M
Total Revenue25.2 M18.5 M
Cost Of Revenue18.2 M13.6 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.06  0.06 
Research And Ddevelopement To Revenue 0  0 
Capex To Revenue(0.02)(0.02)
Revenue Per Share 1.61  2.57 
Ebit Per Revenue 0.12  0.13 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioRem in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioRem's short interest history, or implied volatility extrapolated from BioRem options trading.

Pair Trading with BioRem

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioRem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioRem will appreciate offsetting losses from the drop in the long position's value.

Moving together with BioRem Stock

  0.61RY-PS Royal BankPairCorr

Moving against BioRem Stock

  0.5TD Toronto Dominion BankPairCorr
The ability to find closely correlated positions to BioRem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioRem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioRem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioRem Inc to buy it.
The correlation of BioRem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioRem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioRem Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioRem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for BioRem Stock analysis

When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Please note, there is a significant difference between BioRem's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioRem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioRem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.